Long-Term Assets: The sum of all assets classified as non-current.
Kairos Pharma, Ltd. (KAPA) had Long-Term Assets of $1.89M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.26M |
|
-- |
|
-- |
|
$1.27M |
|
$-1.27M |
|
$0.00M |
|
$-1.26M |
|
$-1.26M |
|
$-1.26M |
|
$-1.26M |
|
$-1.26M |
|
$-1.26M |
|
$-1.27M |
|
$-1.23M |
|
15.88M |
|
15.88M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$6.05M |
|
-- |
|
|
Long-Term Assets |
$1.89M |
$7.94M |
|
$0.81M |
|
-- |
|
-- |
|
$0.81M |
|
$7.13M |
|
$6.95M |
|
$7.13M |
|
15.82M |
|
| Cash Flow Statement Financials | |
$-0.71M |
|
-- |
|
$3.06M |
|
$1.27M |
|
$3.62M |
|
$2.34M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.69% |
|
-18.16% |
|
-15.90% |
|
-17.69% |
|
$0.45 |
|
$-0.04 |
|
$-0.04 |
|